Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
-16.56%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$35.3B
AUM Growth
-$2.37B
(-6.3%)
Cap. Flow
+$3.87B
Cap. Flow
% of AUM
10.98%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
3,022
New
308
Increased
1,176
Reduced
1,104
Closed
401
Top Buys
| 1 |
Netflix
NFLX
|
+$324M |
| 2 |
Altria Group
MO
|
+$252M |
| 3 |
JPMorgan Chase
JPM
|
+$251M |
| 4 |
Meta Platforms (Facebook)
META
|
+$247M |
| 5 |
Intel
INTC
|
+$245M |
Top Sells
| 1 |
CERN
Cerner Corp
CERN
|
+$407M |
| 2 |
AbbVie
ABBV
|
+$284M |
| 3 |
S&P Global
SPGI
|
+$238M |
| 4 |
Eli Lilly
LLY
|
+$213M |
| 5 |
Amazon
AMZN
|
+$188M |
Sector Composition
| 1 | Technology | 24.16% |
| 2 | Healthcare | 18.6% |
| 3 | Financials | 10.46% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Taysha Gene Therapies
TSHA
$884M
| $394K | ﹤0.01% |
105,800
-30,500
| -22% | -$114K |
|
|
EXK
2027
Endeavour Silver
EXK
$1.78B
| $393K | ﹤0.01% |
125,100
+111,700
| +834% | +$351K |
|
2028
ASE Group
ASX
$24.2B
| $391K | ﹤0.01% |
+75,600
| New | +$391K |
|
2029
Scansource
SCSC
$994M
| $391K | ﹤0.01% |
12,563
-5,600
| -31% | -$174K |
|
|
SMED
2030
DELISTED
Sharps Compliance Corp
SMED
| $391K | ﹤0.01% |
133,800
-12,600
| -9% | -$36.8K |
|
|
PLM
2031
DELISTED
PolyMet Mining Corp.
PLM
| $391K | ﹤0.01% |
142,210
+102,000
| +254% | +$280K |
|
2032
Kinsale Capital Group
KNSL
$10.2B
| $390K | ﹤0.01% |
+1,700
| New | +$390K |
|
|
SOHU
2033
Sohu.com
SOHU
$481M
| $388K | ﹤0.01% |
23,400
-28,700
| -55% | -$476K |
|
2034
Innovative Industrial Properties
IIPR
$1.6B
| $385K | ﹤0.01% |
3,500
+1,700
| +94% | +$187K |
|
2035
Nuvation Bio
NUVB
$1.15B
| $385K | ﹤0.01% |
118,700
+97,000
| +447% | +$315K |
|
2036
KLA
KLAC
$127B
| $383K | ﹤0.01% |
1,200
-2,900
| -71% | -$926K |
|
2037
VSE Corp
VSEC
$3.47B
| $383K | ﹤0.01% |
+10,200
| New | +$383K |
|
2038
Westwater Resources
WWR
$59.6M
| $382K | ﹤0.01% |
353,400
-113,600
| -24% | -$123K |
|
2039
Bank First Corp
BFC
$1.26B
| $379K | ﹤0.01% |
5,000
+700
| +16% | +$53.1K |
|
2040
Escalade
ESCA
$173M
| $379K | ﹤0.01% |
+29,201
| New | +$379K |
|
2041
Zymeworks
ZYME
$1.24B
| $379K | ﹤0.01% |
71,600
-232,700
| -76% | -$1.23M |
|
2042
CTS Corp
CTS
$1.26B
| $378K | ﹤0.01% |
11,100
+5,100
| +85% | +$174K |
|
2043
Clear Secure
YOU
$3.58B
| $378K | ﹤0.01% |
+18,900
| New | +$378K |
|
|
DCBO
2044
Docebo
DCBO
$867M
| $376K | ﹤0.01% |
+13,100
| New | +$376K |
|
2045
Matthews International
MATW
$775M
| $376K | ﹤0.01% |
+13,100
| New | +$376K |
|
2046
Rackspace Technology
RXT
$357M
| $376K | ﹤0.01% |
52,500
+18,600
| +55% | +$133K |
|
2047
Adaptive Biotechnologies
ADPT
$2.05B
| $375K | ﹤0.01% |
46,400
+34,300
| +283% | +$277K |
|
2048
BridgeBio Pharma
BBIO
$10.1B
| $375K | ﹤0.01% |
41,280
+13,800
| +50% | +$125K |
|
2049
Northwest Bancshares
NWBI
$1.86B
| $375K | ﹤0.01% |
+29,300
| New | +$375K |
|
|
MSB
2050
Mesabi Trust
MSB
$419M
| $373K | ﹤0.01% |
15,200
-4,500
| -23% | -$110K |
|